Table 2.

Stabilization of platelet HLA-A2 molecules at 37°C after addition of HLA-A2 binding exogenous peptide and β2-microglobulin

Neg. Control W6/32 BB7.2 B1.23.2 CD41
Time 0  17* 450  164  155  1330  
Incubation 24 h at 37°C 
 Medium  15  215  86  54  930 
 β2m + CH10 68-77 18  181  96  80  887 
 β2m + TYBO 11-19  12  193  95  75  905 
 β2m + Mat 58-66  12  271 110 49 913  
 β2m + gp190 367-375  12  311 120 46  940 
Neg. Control W6/32 BB7.2 B1.23.2 CD41
Time 0  17* 450  164  155  1330  
Incubation 24 h at 37°C 
 Medium  15  215  86  54  930 
 β2m + CH10 68-77 18  181  96  80  887 
 β2m + TYBO 11-19  12  193  95  75  905 
 β2m + Mat 58-66  12  271 110 49 913  
 β2m + gp190 367-375  12  311 120 46  940 
*

Staining with MoAbs is expressed as fluorescence mean. For W6.32 and BB7.2 stainings, fluorescence mean increases >20% are indicated in bold.

Platelets were incubated for 24 hours at 37°C in medium alone or in the presence of 100 μg/mL of exogenous peptide and 3 μg/mL of β2-microglobulin (β2m), then stained with different MoAbs as described in Materials and methods.

Mat and gp190 peptides are known HLA-A*0201 binders. CH10 and TYBO peptides, which do not contain any specific HLA-A2 motif were used as negative controls.

Close Modal

or Create an Account

Close Modal
Close Modal